Clinical trials, by definition, need to have an aim, an outcome measure. Indeed, there is no point conducting a trial if there is no endpoint in view. The choice of the outcome measure employed will vary according to the agent/technique being assessed but in intensive care medicine, the majority of clinical trials currently focus on the 28 day all-cause mortality rate. This measure may, however, not necessarily be the most appropriate, and we will discuss the reasons for this, and possible alternatives, in this paper.
Keywords
- Organ Failure
- Sequential Organ Failure Assessment
- Infection Type
- Intensive Care Medicine
- Veteran Administration
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.